Oncology Models | Charles River Discovery Services

Radiation 

Charles River Discovery Services is licensed to carry out biodistribution studies with C14- and H3-labeled molecules. Biodistribution studies with C- and H-labeled molecules help determine the targeting and tumor specificity of a test agent. On-site determination of radiolabeled levels in samples is possible.

We also have the capability of administering radiation as a therapy using a Faxitron Model CP-160 instrument. This capability enables the use of radiation for:

  • Combination radiation/chemotherapy
  • Myeloablation
  • In vitro applications


For more information about our radiation services, please contact us at 1.877.CRIVER.1 or askcharlesriver@crl.com.

Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
May 14 - New Models for Evaluating COPD or ...
May 11 - Expert Safety Testing to Accelerat...
Jun 17-Jun 20 -  Noordwijk aan Zee, the Netherlands - 19th MDO Meeting / 12th European ...
Jun 02-Jun 05 - Vancouver, British Columbia - CALAS
Jun 05-Jun 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Biol...
Jun 05-Jun 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA
Manager International Tax Wilmington, MA

Charles River Laboratories, Inc.